{"pageContent": "Background: Metabolic syndrome (MetS) is considered a potential risk factor for adverse outcomes after radical prostatectomy (RP). Furthermore, studies about the effect of MetS on low-risk prostate cancer (PCa) and its implications in active surveillance (AS) are limited.", "metaData": {"source": "Caregiving and social support for gay and bisexual men with prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/27530377/"}}